lisvy transdermal patch
gedeon richter plc - ethinylestradiol, gestodene - transdermal patch - progestogens and estrogens, fixed combinations
zafrilla 2mg tablets
gedeon richter plc - dienogest - tablet - 2 milligram(s) - dienogest
bromocriptin-richter tablets
gedeon richter plc - bromcriptine (bromocriptine mesilate) - tablets - 2,5mg
vagirux 10 microgram vaginal tablets.
gedeon richter plc gyomroi ut 19-21 1103 budapest, hungary - estradiol hemihydrate - vaginal tablet - estradiol hemihydrate 10 µg - sex hormones and modulators of the genital system
vagirux 10 microgram vaginal tablets
gedeon richter plc - estradiol - vaginal tablet - 10 microgram(s) - estradiol
amlodipine-perindopril-richter tablets
gedeon richter plc - amlodipine (amlodipine besilate), perindipril (perindopril tert-butylamine) - tablets - 10mg+ 8mg
amlodipine-perindopril-richter tablets
gedeon richter plc - amlodipine (amlodipine besilate), perindopril (perindopril tert-butylamine) - tablets - 10mg+ 4mg
amlodipine-perindopril-richter tablets
gedeon richter plc - amlodipine (amlodipine besilate), perindopril (perindopril tert-butylamine) - tablets - 5mg+ 8mg
amlodipine-perindopril-richter tablets
gedeon richter plc - amlodipine (amlodipine besilate), perindopril (perindopril tert-butylamine) - tablets - 5mg+ 4mg
afolia follitropin alfa (rch) 300 iu/0.5 ml (22 microgram) solution for injection cartridge in a pre-filled pen
gedeon richter australia pty ltd - follitropin alfa, quantity: 300 iu - injection, solution - excipient ingredients: poloxamer; sucrose; dibasic sodium phosphate dihydrate; monobasic sodium phosphate dihydrate; methionine; phosphoric acid; thymidine; trypsin - in adult women:,- afolia is indicated for the treatment of anovulatory infertility in women who have been unresponsive to clomiphene citrate or where clomiphene citrate is contraindicated,- controlled ovarian hyperstimulation in women undergoing assisted reproductive technologies,- afolia in association with a luteinising hormone (lh) preparation is recommended for the stimulation of follicular development in women with severe lh and fsh deficiency. in clinical trials these patients were defined by an endogenous serum lh level <1.2 iu/l.,in adult men:,- afolia is indicated with concomitant human chorionic gonadotrophin (hcg) therapy for the stimulation of spermatogenesis in gonadotrophin-deficient men in whom hcg alone is ineffective.